1. Home
  2. PMCB vs CCHH Comparison

PMCB vs CCHH Comparison

Compare PMCB & CCHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

N/A

Current Price

$0.69

Market Cap

8.3M

Sector

Health Care

ML Signal

N/A

CCHH

CCH Holdings Ltd Ordinary Shares

N/A

Current Price

$0.70

Market Cap

10.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PMCB
CCHH
Founded
1996
2015
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
10.2M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
PMCB
CCHH
Price
$0.69
$0.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
112.4K
2.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
277.22
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$43.55
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.36
52 Week High
$1.73
$15.39

Technical Indicators

Market Signals
Indicator
PMCB
CCHH
Relative Strength Index (RSI) 46.59 47.52
Support Level $0.65 $0.44
Resistance Level $0.77 $0.76
Average True Range (ATR) 0.06 0.14
MACD 0.00 0.03
Stochastic Oscillator 42.23 28.93

Price Performance

Historical Comparison
PMCB
CCHH

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About CCHH CCH Holdings Ltd Ordinary Shares

CCH Holdings Ltd operates a hotpot restaurant chain in Malaysia, specializing in chicken hotpot and fish head hotpot, mainly under two brand, namely Chicken Claypot House and Zi Wei Yuan, owned by the wholly owned subsidiaries of the Company. The Company conducts its operations through its wholly owned subsidiaries in Malaysia and is engaged as a restaurant operator, licensor and loyalty owner, and general trader. Currently, the Group has developed a restaurant chain including approximately 15 company-owned restaurant outlets, 13 franchised restaurant outlets in Malaysia, and 4 franchised restaurant outlets outside Malaysia.

Share on Social Networks: